"Photosensitizing Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs that are pharmacologically inactive but when exposed to ultraviolet radiation or sunlight are converted to their active metabolite to produce a beneficial reaction affecting the diseased tissue. These compounds can be administered topically or systemically and have been used therapeutically to treat psoriasis and various types of neoplasms.
| Descriptor ID |
D017319
|
| MeSH Number(s) |
D27.505.954.444.600 D27.505.954.600.710
|
| Concept/Terms |
Photosensitizing Effect- Photosensitizing Effect
- Effect, Photosensitizing
- Photosensitizing Effects
- Effects, Photosensitizing
|
Below are MeSH descriptors whose meaning is more general than "Photosensitizing Agents".
Below are MeSH descriptors whose meaning is more specific than "Photosensitizing Agents".
This graph shows the total number of publications written about "Photosensitizing Agents" by people in this website by year, and whether "Photosensitizing Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2013 | 1 | 1 | 2 |
| 2014 | 1 | 2 | 3 |
| 2015 | 2 | 0 | 2 |
| 2016 | 3 | 2 | 5 |
| 2018 | 2 | 0 | 2 |
| 2019 | 1 | 2 | 3 |
| 2020 | 3 | 1 | 4 |
| 2021 | 1 | 2 | 3 |
| 2024 | 0 | 2 | 2 |
| 2025 | 3 | 2 | 5 |
| 2026 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Photosensitizing Agents" by people in Profiles.
-
Parameter-Dependent Effects of Rose Bengal Photodynamic Antimicrobial Therapy on MRSA Inhibition and Corneal Cytokine Expression. Transl Vis Sci Technol. 2026 Apr 06; 15(4):14.
-
Evaluating Photochemical Interactions Between Rose Bengal Photodynamic Antimicrobial Therapy and Topical Antifungals in Fungal Keratitis Isolates. Invest Ophthalmol Vis Sci. 2026 Jan 05; 67(1):11.
-
Predictors of vision-related quality of life in patients treated for filamentous fungal keratitis. Ocul Surf. 2025 Oct; 38:319-323.
-
Systematic Targeting of GD2-Positive Neuroblastoma Tumors With a Photooncolytic Phage Nanovector Platform. Adv Sci (Weinh). 2025 Oct; 12(38):e15356.
-
Rose Bengal photodynamic antimicrobial therapy as an adjunct treatment for Pseudomonas aeruginosa infectious necrotizing scleritis. Photodiagnosis Photodyn Ther. 2025 Jun; 53:104575.
-
Systemic antitumor immune response of doped yttria nanoscintillators under low-dose x-ray irradiation. Sci Adv. 2025 Mar 28; 11(13):eadr4008.
-
A Powerful Organic Photosensitizer for Effective Treatment of Malignant Tumors Via Activating Antitumor Immunity. Chembiochem. 2025 Feb 03; 26(5):e202400975.
-
Therapies for Central Serous Chorioretinopathy: A Report by the American Academy of Ophthalmology. Ophthalmology. 2025 Mar; 132(3):343-353.
-
Variations in irradiation energy and rose bengal concentration for photodynamic antimicrobial therapy of fungal keratitis isolates. Lasers Med Sci. 2024 Feb 21; 39(1):72.
-
Clinical impact of the worldwide shortage of verteporfin (Visudyne?) on ophthalmic care. Acta Ophthalmol. 2022 Nov; 100(7):e1522-e1532.